← Back
$SPRY All transactions

ARS Pharmaceuticals, Inc.

▼ SELL

$ Value

$267K

Shares

30,000

Price

$9

Filed

Nov 14

Insider

Name

Chakma Justin

Title

Chief Business Officer

CIK

0001951238

Roles

Officer

Transaction Details

Transaction Date

2025-11-12

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

136,380

Footnotes

The weighted average sale price for the transaction reported was $8.9119, and the range of prices was between $8.87 and $8.97. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. | The weighted average sale price for the transaction reported was $8.8634, and the range of prices was between $8.62 and $9.04. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. | Immediately exercisable.

Filing Info

Accession No.

0001951238-25-000005

Form Type

4

Issuer CIK

0001671858

Chakma Justin's History

Date Ticker Type Value
2025-11-12 SPRY M $25K
2025-11-12 SPRY $267K
2025-11-12 SPRY $1.2M
2025-11-12 SPRY M $0

Other Insiders at SPRY (90d)

No other insider activity at this issuer in the last 90 days.